Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum
  2. Bennett, John M; Ward, Kurt E; Muir, Ryan K; Kabeche, Stephanie; Yoo,Euna; Yeo, Tomas; Lam, Grace; Zhang, Hao; Almaliti, Jehad; Berger, Gabriel; Faucher, Franco F; Lin, Gang; Gerwick, William H; Yeh, Ellen; Fidock, David A; Bogyo, Matthew
  3. ACS Infectious Diseases. 2023, Oct 13; 9(10): 2036-2047.
  1. 2.   Small cyclic sodium channel inhibitors
  2. Peigneur, Steve; da Costa Oliveira, Cristina; de Sousa Fonseca, Flávia Cristina; McMahon, Kirsten L; Mueller, Alexander; Cheneval, Olivier; Cristina Nogueira Freitas, Ana; Starobova, Hana; Dimitri Gama Duarte, Igor; Craik, David J; Vetter, Irina; de Lima, Maria Elena; Schroeder,Christina; Tytgat, Jan
  3. Biochemical Pharmacology. 2021, Jan; 183: 114291.
  1. 3.   Optimization of sortase A ligation for flexible engineering of complex protein systems
  2. Li,Jess; Zhang,Yue; Soubias,Olivier; Khago,Domarin; Chao, Fa-an; Li, Yifei; Shaw, Katherine; Byrd,Robert
  3. JOURNAL OF BIOLOGICAL CHEMISTRY. 2020, FEB 28; 295(9): 2664-2675.
  1. 4.   Histidine N(t)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors
  2. Hymel, David; Grant, Robert A; Tsuji, Kohei; Yaffe, Michael B; Burke, Terrence
  3. Bioorganic & medicinal chemistry letters. 2018, Oct 15; 28(19): 3202-3205.
  1. 5.   A Synthetic Mirror Image of Kalata B1 Reveals that Cyclotide Activity Is Independent of a Protein Receptor
  2. Sando, L.; Henriques, S. T.; Foley, F.; Simonsen, S. M.; Daly, N. L.; Hall, K. N.; Gustafson, K. R.; Aguilar, M. I.; Craik, D. J.
  3. Chembiochem. 2011, Nov; 12(16): 2456-2462.
  1. 6.   Design and synthesis of paclitaxel conjugated with an ErbB2-Recognizing pepticle, EC-1
  2. Li, P.; Jiang, S.; Pero, S. C.; Oligino, L.; Krag, D. N.; Michejda, C. J.; Roller, P. P.
  3. Biopolymers. 2007, Nov; 87(4): 225-230.
  1. 7.   Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimics
  2. Jiang, S.; Li, P.; Peach, M. L.; Bindu, L.; Worthy, K. W.; Fisher, R. J.; Burke, T. R.; Nicklaus, M.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2006, Oct; 349(2): 497-503.
  1. 8.   Design and concise synthesis of fully protected analogues of L-gamma-carboxyglutamic acid
  2. Jiang, S.; Li, P.; Lai, C. C.; Kelley, J. A.; Roller, P. P.
  3. Journal of Organic Chemistry. 2006, Sep; 71(19): 7307-7314.
  1. 9.   A practical synthesis of fully protected L-gamma-carboxyglutamic acid
  2. Jiang, S.; Lai, C. C.; Kelley, J. A.; Roller, P. P.
  3. Tetrahedron Letters. 2006, Jan; 47(1): 23-25.
  1. 10.   Isolation and characterization of novel cyclotides from Viola hederaceae - Solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide
  2. Chen, B.; Colgrave, M. L.; Daly, N. L.; Rosengren, K. J.; Gustafson, K. R.; Craik, D. J.
  3. Journal of Biological Chemistry. 2005, JUN 10; 280(23): 22395-22405.
  1. 11.   Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin
  2. Shi, Y. H.; Song, Y. L.; Lin, D. H.; Tan, J. Z.; Roller, P. P.; Li, Q.; Long, Y. Q.; Song, G. Q.
  3. Biochemical and Biophysical Research Communications. 2005, MAY 20; 330(4): 1254-1261.
  1. 12.   Structure of circulin B and implications for antimicrobial activity of the cyclotides
  2. Koltay, A.; Daly, N. L.; Gustafson, K. R.; Craik, D. J.
  3. International Journal of Peptide Research and Therapeutics. 2005, MAR; 11(1): 99-106.
  1. 13.   Anti-HIV cyclotides
  2. Gustafson, K. R.; McKee, T. C.; Bokesch, H. R.
  3. Current Protein & Peptide Science. 2004, OCT; 5(5): 331-340.
  1. 14.   The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1
  2. Daly, N. L.; Gustafson, K. R.; Craik, D. J.
  3. Febs Letters. 2004, SEP 10; 574(1-3): 69-72.
  1. 15.   Development of L-3-aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity
  2. Song, Y. L.; Roller, P. P.; Long, Y. Q.
  3. Bioorganic & Medicinal Chemistry Letters. 2004 14(12): 3205-3208.
  1. 16.   Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain
  2. Long, Y. Q.; Guo, R. B.; Luo, J. H.; Yang, D. J.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2003 310(2): 334-340.
  1. 17.   Structural basis for a non-phosphorus-containing cyclic peptide binding to Grb2-SH2 domain with high affinity
  2. Li, P.; Zhang, M. C.; Peach, M. L.; Zhang, X. D.; Liu, H. P.; Nicklaus, M.; Yang, D. J.; Roller, P. P.
  3. Biochemical and Biophysical Research Communications. 2003 307(4): 1038-1044.
  1. 18.   Design and synthesis of potent Grb2-SH2 domain antagonists based upon phage library derived cyclic peptide G1TE
  2. Li, P.; Zhang, M. C.; Peach, M. L.; Yang, D. J.; Roller, P. P.
  3. Abstracts of Papers of the American Chemical Society. 2003 225(Part 2): U192-U192.
  1. 19.   Solution structure by NMR of circulin A: A macrocyclic knotted peptide having anti-HIV activity
  2. Daly, N. L.; Koltay, A.; Gustafson, K. R.; Boyd, M. R.; Casas-Finet, J. R.; Craik, D. J.
  3. Journal of Molecular Biology. 1999 285(1): 333-345.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel